Nathaniel S. Gardiner
2021
Compensation breakdown
| Non-Equity Incentive Plan | $198,702 |
|---|---|
| Option Awards | $652,535 |
| Salary | $444,675 |
| Stock Awards | $582,640 |
| Other | $19,211 |
| Total | $1,897,763 |
Gardiner received $652.5K in option awards, accounting for 34% of the total pay in 2021.
Gardiner also received $198.7K in non-equity incentive plan, $444.7K in salary, $582.6K in stock awards and $19.2K in other compensation.
Rankings
In 2021, Nathaniel S. Gardiner's compensation ranked 6,239th out of 12,397 executives tracked by ExecPay. In other words, Gardiner earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,239 out of 12,397 | 50th |
Division Manufacturing | 2,644 out of 5,492 | 52nd |
Major group Chemicals And Allied Products | 1,157 out of 2,367 | 51st |
Industry group Drugs | 1,030 out of 2,090 | 51st |
Industry Pharmaceutical Preparations | 745 out of 1,537 | 52nd |
Pay ratio
| Nathaniel S. Gardiner's Pay | $1,897,763 |
|---|---|
| Median Employee's Pay | $230,731 |
| Pay Ratio | to 1 |
In 2021, the annual total compensation of Nathaniel S. Gardiner was $1,897,763.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $230,731.
The ratio of Nathaniel S. Gardiner's pay to the pay of median employee was therefore to one.
Gardiner's colleagues
We found five more compensation records of executives who worked with Nathaniel S. Gardiner at Enanta Pharmaceuticals in 2021.
2021
Jay Luly
Enanta Pharmaceuticals
Chief Executive Officer
2021
Brendan Luu
Enanta Pharmaceuticals
Senior Vice President, Business Development
2021
Tara Kieffer
Enanta Pharmaceuticals
Senior Vice President, New Product Strategy & Development
2021
Yat Or
Enanta Pharmaceuticals
Chief Scientific Officer
2021
Paul Mellett
Enanta Pharmaceuticals
Chief Financial Officer
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019